Background: Opioid use is classified as an epidemic by many due to the impact of these medications on society. Federal and state laws for prescribing and dispensing opioids have changed rapidly in a short period of time to hopefully balance proper pain control with their use. Pharmacy directors must be informed of these rapid changes to effectively work as part of any opioid stewardship team. Objective: The objective of this study was to provide foundational leadership guidance to pharmacy directors on current opioid legislation, literature, and best practices to assist in improving opioid use. Methods: A review of the literature from 2003 to the present was conducted along with collating important up to date resources and other publications that provide foundational information to help support a comprehensive management of opioid use. A summary of these data has been collated into an easy to use table and summarized throughout this article. Conclusion: The information provided in this article helps to properly inform pharmacy leaders to the resources available to improve the prescribing, dispensing, and monitoring of opioids and alternatives.
Background: Opioid use is classified as an epidemic by many due to the impact of these medications on society. Federal and state laws for prescribing and dispensing opioids have changed rapidly in a short period of time to hopefully balance proper pain control with their use. Pharmacy directors must be informed of these rapid changes to effectively work as part of any opioid stewardship team. Objective: The objective of this study was to provide foundational leadership guidance to pharmacy directors on current opioid legislation, literature, and best practices to assist in improving opioid use. Methods: A review of the literature from 2003 to the present was conducted along with collating important up to date resources and other publications that provide foundational information to help support a comprehensive management of opioid use. A summary of these data has been collated into an easy to use table and summarized throughout this article. Conclusion: The information provided in this article helps to properly inform pharmacy leaders to the resources available to improve the prescribing, dispensing, and monitoring of opioids and alternatives.
Authors: Lee C Vermeulen; Natalie D Eddington; Michelle A Gourdine; James Jorgenson; David A Kvancz; Suzanne A Nesbit; Mark C Bicket; William A Zellmer; Amanda Hine; Sylvia Belford; Steve G Peters; James M Hoffman; William E Schwab; Scott Knoer; Delos Toby Cosgrove; Stanley S Kent; John S Clark Journal: Am J Health Syst Pharm Date: 2019-01-16 Impact factor: 2.637
Authors: Richard A Mularski; Foy White-Chu; Devorah Overbay; Lois Miller; Steven M Asch; Linda Ganzini Journal: J Gen Intern Med Date: 2006-06 Impact factor: 5.128
Authors: Elizabeth M Oliva; Melissa L D Christopher; Daina Wells; Mark Bounthavong; Michael Harvey; Julianne Himstreet; Thomas Emmendorfer; Michael Valentino; Mariano Franchi; Francine Goodman; Jodie A Trafton Journal: J Am Pharm Assoc (2003) Date: 2017 Mar - Apr